Literature DB >> 16007220

The tumor suppressor WARTS activates the Omi / HtrA2-dependent pathway of cell death.

Shinji Kuninaka1, Masanobu Nomura, Toru Hirota, Shin-Ichi Iida, Toshihiro Hara, Shinobu Honda, Naoko Kunitoku, Takashi Sasayama, Yoshimi Arima, Tomotoshi Marumoto, Kageharu Koja, Shin Yonehara, Hideyuki Saya.   

Abstract

Drosophila tumor suppressor WARTS (Wts) is an evolutionally conserved serine / threonine kinase and participates in a signaling complex that regulates both proliferation and apoptosis to ensure the proper size and shape of the fly. Human counterparts of this complex have been found to be frequently downregulated or mutated in cancers. WARTS, a human homolog of Wts, is also known as tumor suppressor and mitotic regulator, but its molecular implications in tumorigenesis are still obscure. Here, we show that WARTS binds via its C-terminus to the PDZ domain of a proapoptotic serine protease Omi / HtrA2. Depletion of WARTS inhibited Omi / HtrA2-mediated cell death, whereas overexpression of WARTS promoted this process. Furthermore, WARTS can enhance the protease activity of Omi / HtrA2 both in vivo and in vitro. Activation of Omi / HtrA2-mediated cell death is thus a potential mechanism for the tumor suppressive activity of WARTS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16007220     DOI: 10.1038/sj.onc.1208682

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  The anaphase-promoting complex/cyclosome activator Cdh1 modulates Rho GTPase by targeting p190 RhoGAP for degradation.

Authors:  Hideaki Naoe; Kimi Araki; Osamu Nagano; Yusuke Kobayashi; Jo Ishizawa; Tatsuyuki Chiyoda; Takatsune Shimizu; Ken-ichi Yamamura; Yutaka Sasaki; Hideyuki Saya; Shinji Kuninaka
Journal:  Mol Cell Biol       Date:  2010-06-07       Impact factor: 4.272

Review 2.  Cytokine-induced tumor suppressors: a GRIM story.

Authors:  Dhan V Kalvakolanu; Shreeram C Nallar; Sudhakar Kalakonda
Journal:  Cytokine       Date:  2010-04-10       Impact factor: 3.861

3.  The member of high temperature requirement family HtrA2 participates in neuronal apoptosis after intracerebral hemorrhage in adult rats.

Authors:  Huiqing Sun; Lei Li; Feng Zhou; Lin Zhu; Kaifu Ke; Xiang Tan; Wei Xu; Ying Rui; Heyi Zheng; Zhengming Zhou; Huiguang Yang
Journal:  J Mol Histol       Date:  2013-02-15       Impact factor: 2.611

Review 4.  The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway.

Authors:  Noa Furth; Yael Aylon
Journal:  Cell Death Differ       Date:  2017-06-23       Impact factor: 15.828

5.  Structural basis of protein substrate processing by human mitochondrial high-temperature requirement A2 protease.

Authors:  Yuki Toyama; Robert W Harkness; Lewis E Kay
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-22       Impact factor: 12.779

6.  Lats2 is a negative regulator of myocyte size in the heart.

Authors:  Yutaka Matsui; Noritsugu Nakano; Dan Shao; Shumin Gao; Wenting Luo; Chull Hong; Peiyong Zhai; Eric Holle; Xianzhong Yu; Norikazu Yabuta; Wufan Tao; Thomas Wagner; Hiroshi Nojima; Junichi Sadoshima
Journal:  Circ Res       Date:  2008-10-16       Impact factor: 17.367

7.  Ovarian serous carcinomas acquire cisplatin resistance and increased invasion through downregulation of the high-temperature-required protein A2 (HtrA2), following repeated treatment with cisplatin.

Authors:  Hiroaki Soyama; Morikazu Miyamoto; Masashi Takano; Tadashi Aoyama; Hiroko Matsuura; Takahiro Sakamoto; Kazuki Takasaki; Mika Kuwahara; Kento Kato; Tomoyuki Yoshikawa; Hideki Iwahashi; Hitoshi Tsuda; Kenichi Furuya
Journal:  Med Oncol       Date:  2017-11-22       Impact factor: 3.064

8.  THAP5 is a human cardiac-specific inhibitor of cell cycle that is cleaved by the proapoptotic Omi/HtrA2 protease during cell death.

Authors:  Meenakshi P Balakrishnan; Lucia Cilenti; Zineb Mashak; Paiyal Popat; Emad S Alnemri; Antonis S Zervos
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-05       Impact factor: 4.733

9.  LATS1/WARTS phosphorylates MYPT1 to counteract PLK1 and regulate mammalian mitotic progression.

Authors:  Tatsuyuki Chiyoda; Naoyuki Sugiyama; Takatsune Shimizu; Hideaki Naoe; Yusuke Kobayashi; Jo Ishizawa; Yoshimi Arima; Hiroshi Tsuda; Masaaki Ito; Kozo Kaibuchi; Daisuke Aoki; Yasushi Ishihama; Hideyuki Saya; Shinji Kuninaka
Journal:  J Cell Biol       Date:  2012-05-28       Impact factor: 10.539

10.  The NG2 Proteoglycan Protects Oligodendrocyte Precursor Cells against Oxidative Stress via Interaction with OMI/HtrA2.

Authors:  Frank Maus; Dominik Sakry; Fabien Binamé; Khalad Karram; Krishnaraj Rajalingam; Colin Watts; Richard Heywood; Rejko Krüger; Judith Stegmüller; Hauke B Werner; Klaus-Armin Nave; Eva-Maria Krämer-Albers; Jacqueline Trotter
Journal:  PLoS One       Date:  2015-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.